Aging Is a Loss of Coordination Between Organ Systems
How well is my body aging and what can I do to influence it?
Last week, we established that curing heart disease might add roughly two years to average life expectancy. Curing cancer, slightly more. The reason isn’t that medical research is failing; it’s that those diseases are consequences of a deeper process that medicine has, until recently, largely ignored.
So, if the disease-first model is the wrong approach, what does the right solution look like?
Aging Is Not a List — It’s a System Failing
The best way to understand modern geroscience’s central insight is this: aging is not a collection of independent problems that accumulate over time. It’s a progressive loss of coordination among biological systems designed to work together.
Dr. Marvin Edeas, who organized the Targeting Longevity 2026 Congress in Berlin, has clearly articulated this framing. Metabolism, immune function, mitochondrial energy production, and the gut microbiome don’t operate in separate silos. They communicate constantly. They regulate each other.
When that communication degrades, when the crosstalk breaks down, you don’t get one disease. You get a cluster of conditions, each reflecting a different expression of the same underlying system’s failure.
Think about what happens in practice after age 50. Mitochondrial efficiency declines, producing less cellular energy and more oxidative stress. That oxidative stress promotes low-grade chronic inflammation, some call it “inflammaging”. Meanwhile, the gut microbiome shifts toward a less diverse, more pro-inflammatory composition as well, which feeds back into metabolic dysfunction and immune dysregulation. None of these processes is happening independently. They are amplifying each other.
This is why a person in their 60s rarely has one problem. They tend to get three or four: hypertension, pre-diabetes, early cognitive changes, and inflammatory joint disease. The typical GP’s response may be to send them to four different specialists. The geroscience response is to recognize these as four outputs of one aging system that is losing coherence.
A Better Map: The 12 Hallmarks of Aging
In 2013, a landmark paper by López-Otín and colleagues in Cell identified nine biological hallmarks of aging, the core cellular and molecular mechanisms that drive the aging process across species. This framework replaced vague labeling of aging as “wear and tear” with a precise scientific vocabulary.
A decade later, a 2023 update in the same journal expanded the list to twelve hallmarks:
Genomic instability - Gradual buildup of DNA damage and mutations over time.
Telomere attrition - Gradual shortening of the protective caps at the ends of chromosomes, which limits how many times a cell can divide and contributes to aging.
Epigenetic alterations - Age-related changes in gene regulation that change how genes are turned on or off without changing the DNA sequence itself.
Loss of proteostasis - The cell loses its ability to make, fold, and clear proteins properly, leading to damaged or misfolded protein buildup.
Disabled macroautophagy - The cell’s internal recycling system becomes less effective, so damaged components are not removed efficiently.
Deregulated nutrient sensing - The signaling pathways that detect energy and nutrients become poorly regulated, pushing metabolism toward faster aging
Mitochondrial dysfunction - Mitochondria work less efficiently with age, reducing energy production and increasing cellular stress (Mitochondria are tiny power companies in each of your cells).
Cellular senescence - Damaged cells stop dividing but do not die, and they often release inflammatory signals that harm nearby tissue.
Stem cell exhaustion - Stem cells lose their ability to renew and repair tissues effectively over time.
Altered intercellular communication - Cells communicate less accurately with each other, disrupting coordination across tissues and organs.
Chronic inflammation (inflammaging) - Persistent, low-grade inflammation increases with age and helps drive many age-related diseases
Dysbiosis (gut microbiome imbalance) - The gut microbiome shifts into an unhealthy balance that can worsen inflammation, metabolism, and immune function.
The three additions: “macroautophagy dysfunction, inflammaging, and dysbiosis” — reflect how much the field has learned, particularly about the gut-immune-mitochondria axis and the role of persistent, low-grade inflammation as both a cause and consequence of biological aging.
What makes the hallmarks framework clinically useful isn’t just the list itself. It’s the logic underlying it: a process qualifies as a hallmark of aging only if (1) it worsens with age, (2) accelerating it experimentally speeds up aging, and (3) therapeutically targeting it slows or reverses aging. This standard transforms the hallmarks from a descriptive catalog into a target list for intervention.
One of the more significant recent developments is the formal incorporation of psychosocial and social factors as hallmarks of aging. A 2025 paper in a peer-reviewed geromedicine journal proposed that chronic psychosocial adversity (poverty, loneliness, chronic stress, social isolation) satisfies the same three-part criteria as the biological hallmarks. Differences in socioeconomic status and the absence of social support can shift the onset of age-related diseases by more than a decade, an effect comparable to many pharmacological risk factors.
Social connection is no longer a soft factor in longevity medicine. It belongs in the same category as somatic biological effects mentioned above.
Precision Geromedicine: The Clinical Model Emerging Now
The hallmarks framework has given rise to a clinical approach called precision geromedicine. The goal is to match specific aging interventions to individual biological aging profiles, rather than applying one-size-fits-all treatments.
Professor Andrea Maier at the National University of Singapore, writing in the 2025 geroscience expert roundup, described the shift precisely: by the end of 2025, the field moved from “promising biomarkers” to clinically deployable aging phenotypes combining multi-omic biological clocks, digital mobility signatures, and organ-specific functional reserves. In practical terms, this means clinicians will increasingly be able to identify which hallmarks are most active in a given patient and intervene accordingly, rather than waiting for a diagnosable disease to appear.
The first human trials targeting aging mechanisms directly are already underway. The TAME trial - Targeting Aging with Metformin is enrolling over 3,000 adults aged 65 to 79 across 14 research institutions in the United States. The primary outcome is not a single disease endpoint. It measures whether metformin delays the composite onset of cardiovascular disease, cancer, dementia, and death simultaneously.
If it does, the FDA will be asked to recognize aging itself as a treatable indication for the first time in regulatory history. That would be a significant shift in how medicine approaches everyone over 50.
Alongside TAME, a separate class of drugs called senolytics (compounds designed to selectively clear senescent cells) is entering clinical trials. A 2026 pilot study of the combination dasatinib plus quercetin in patients with diabetic kidney disease found reductions in systemic inflammation, senescent cell burden, and tissue injury markers. These are early results in a specific population, but they represent proof that the hallmarks framework can generate clinical-grade, testable interventions and not just biological theory.
What This Means for You After 50
The shift from disease-first to biological aging-first medicine has practical implications that don’t require waiting for TAME trial results or FDA approval.
First, think in systems, not in diagnoses. If you’re managing more than one chronic condition, ask whether they may share a common biological driver such as inflammation, metabolic dysregulation, or mitochondrial decline. A physician familiar with geroscience can help you think about root causes, not just symptom management.
Second, the lifestyle factors that target multiple hallmarks simultaneously are already well-established. Regular aerobic exercise improves mitochondrial biogenesis, reduces inflammaging, and supports gut microbiome diversity (three hallmarks addressed by one intervention). Resistance training preserves muscle mass and improves nutrient sensing. Sleep quality directly influences protein clearance (proteostasis), immune regulation, and metabolic function.
None of this is new advice. What is new is that we now understand why these interventions work at the biological level on multiple fronts of aging.
Third, social connection is not optional. The evidence that chronic loneliness and social isolation accelerate biological aging (at the molecular level) is strong enough that it belongs alongside sleep, diet, and exercise in any serious longevity conversation. A 2025 Cornell study found that accumulated social support across a lifetime is associated with measurably slower epigenetic aging.
Fourth, ask your doctor about biological age, not just chronological age. Multi-omic aging clocks are moving from research settings into clinical platforms. They are not yet fully standardized, and significant variability remains between commercial products. But the underlying question: “how is my body actually aging relative to my chronological age?” is starting to be a legitimate clinical question that more physicians will soon be equipped to answer.
Where Is This Headed?
The researchers in this field are consistent on one point: the era of treating aging as an inevitable background process is ending. The 2026 Longevity World Forum consensus was that targeting the biology of aging and not chasing individual diseases one at a time is the path toward meaningful healthspan extension.
You don’t need to wait. The science already points you toward a set of behaviors that work upstream, at the level of aging. You need to educate yourself and start doing your part!